KOR

e-Article

Dipeptidyl peptidase-1 inhibition in patients hospitalised with COVID-19: a multicentre, double-blind, randomised, parallel-group, placebo-controlled trial
Document Type
Article
Author
Keir, Holly RLong, Merete BAbo-Leyah, HaniGiam, Yan HuiVadiveloo, ThenmalarPembridge, ThomasHull, Rebecca CDelgado, LiliaBand, MargaretMcLaren-Neil, FionaAdamson, SimonLahnsteiner, EvaGilmour, AmyHughes, ChloeNew, Benjamin JMConnell, DavidDowey, RebeccaTurton, HelenaRichardson, HollianCassidy, DianeCooper, JamieSuntharalingam, JayDiwakar, LavanyaRussell, PeterUnderwood, JonathanHicks, AlexanderDosanjh, Davinder PSSage, BethDhasmana, DeveshSpears, MarkThompson, AA RogerBrightling, ChristopherSmith, AndrewPatel, ManishGeorge, JacobCondliffe, Alison MShoemark, AmeliaMacLennan, GraemeChalmers, James DChalmers, JamesAbo-Leyah, HaniNew, Benjamin JMAlmaden-Boyle, ChristineConnell, DavidTaylor, JenniferStrachan, JodieLoftus, HeatherYoung, LesleyStrachan, AngelaBand, MargaretMcLaren-Neil, FionaPilvinyte, KristinaAdamson, SimonLahnsteiner, EvaRauchhaus, PetraHogarth, FionaGeorge, JacobBurns, TriciaCoote, ElizabethKeiller, MarneyPatel, ManishSmith, AndrewSage, ElizabethCooper, JamieMiller, DavidDosanjh, DavinderSutton, BenjaminUnderwood, JonathanFrayling, SharonHaynes, MatthewBroad, LaurenJones, LauraRahilly, KarenOliver, CatherineEvans, TerriannBalan, AndreaDavies, RhysForde, DonalNye, ClemencyHaboubi, DrHilton, ZoeWilliams, JennieMcQueen, AlisonSpears, MarkEdmond, IanSalutous, DarioMcGenily, LauraScott, RhonaHenderson, EilidhCollins, AndreaDhasmana, DeveshLiu, PatrickMorrow, AnaCouser, MandyDavey, FleurHicks, AlexanderWiffen, LauraFox, LaurenAbdelrahim, MohamedDarbyshire, AlexanderCowen, ElenaRowley, MeganGiles, BenjaminYang, YingjiaBrown, TomRupani, HitashaHawes, ElizabethBarnes, DebiBrogan, FionaBungue-Tuble, RoneleehHowe, SerenaTurner, CharlotteBaryschpolec, SoniaLonghurst, BevMoon, MariaWatkins, LynnBaker-Moffat, MichelleMurray, LisaHarrington-Davies, YasminBurrows, KateMinnis, ChrissieWands, MaryBamgboye, AdefunkeWong, CharlotteBrightling, ChristopherDiver, SarahRussell, RichardMcAuley, HamishElneima, OmerYousuf, AhmedMcCourt, PaulaHargadon, BeverleyParker, SarahBourne, MichelleSuntharalingam, JayHartley, TomMasan, VidanSturney, SharonMacKenzie, RobMarchand, ClareMason, RebeccaWhite, KatieKirby, AlisonMeda, ManjulaDiwakar, LavanyaRussell, PeterFinn, JoanneHarris, SophieMuir, CarolCook, GemmaStaines, NikkiCook, ChrisThompson, AA RogerCondliffe, AlisonHull, RebeccaDowey, RebeccaTurton, HelenaCollini, PaulGabriel, ZoéHardman, SimonNewell, HelenMiddle, JanetSimpson, PhillipColton, HayleyBarker, JoannBirchall, KatieHarrington, KateHousley, KayLenagh, RebeccaWilson, JayneWesonga, JoanWhitham, RachelBird, SarahJackson, YvonneMbuyisa, AngelineAnderson, SamanthaWilson, AnnaKibutu, FaithWalker, SaraCawthron, KayMacharia, IreneSmart, LynneEmery, AnnaHowell, AliceHurditch, ElizabethFord, AmberTurner, KimWatson, LisaBowler, HelenJackson, TracyJaques, CarolDyer, NicholeDucker, ShelleyGoodall, VickyUdale, Emily
Source
The Lancet Respiratory Medicine; December 2022, Vol. 10 Issue: 12 p1119-1128, 10p
Subject
Language
ISSN
22132600; 22132619
Abstract
Neutrophil serine proteases are involved in the pathogenesis of COVID-19 and increased serine protease activity has been reported in severe and fatal infection. We investigated whether brensocatib, an inhibitor of dipeptidyl peptidase-1 (DPP-1; an enzyme responsible for the activation of neutrophil serine proteases), would improve outcomes in patients hospitalised with COVID-19.